Creative Proteomics is a world-leading company that can provide the best solutions for global customers in the field of microarrays. We have successfully developed a variety of peptide array products and corresponding detection services for human immune-related diseases to accelerate the high-throughput detection of potential biological targets in biological samples. We guarantee to provide first-class products and excellent service to customers all over the world.
Although the antigen-antibody complex is a core participant in an effective immune response, it is difficult to accurately find the interactions associated with a specific disease state. The continuous development of molecular biotechnology has been able to meet the possibility of high-throughput screening. Many discoveries have been explored through these methods, and the deciphering of these interactions can greatly facilitate the development of new diagnostic and therapeutic methods. Antigen array technology can analyze the specificity of antibody responses against autoantigens, tumor antigens and microbial antigens on a large scale. Antigen microarrays constitute a new tool for studying the immune response of autoimmune diseases and other diseases (such as tumors and allergies). Our antigen array can be used for multiple purposes in the research of immune-related diseases. For example, it is used to diagnose disease, monitor disease progression and response to treatment, discover pathogenesis, and customize antigen-specific therapies for the autoimmune response of individual patients.
Application
This series includes a total of 7 products, aimed at identifying specific peptide epitopes in some immune-related diseases. Autoimmune peptide microarrays provide linear autoimmune epitopes related to lupus erythematosus, and some tumor-associated antigen peptide microarrays provide tumor-related linear immune epitopes. These products can be used to identify unknown autoimmune diseases in patient serum, correlate autoantibody-specific IgG or IgM response profiles with pathogenesis, and discover new prognostic marker peptides. It can also be used to explore the differential antibody response of autoimmune patient groups or to distinguish multiple autoimmune diseases. The antigen peptide array can be used to screen allergens and develop disease-related drugs. Antigenic peptide microarrays are powerful tools for many applications, including autoantibody detection, biomarker analysis, and characterization of protein-molecule interactions. In addition, antigen peptide microarrays can detect antibodies or other biomarkers present in patient samples in parallel. Proteins associated with specific diseases are selected based on a comprehensive review of publications.
Features of Product
- Multiplexing capability;
- Fast, high throughput;
- High sensitivity (pg/ml);
- Small sample size;
- Industry-leading quality;
Creative Proteomics provides high-quality antigen peptide array products and rapid detection services. We can provide commercialized chips and customized chip services for the research of immune-related diseases according to your research goals. With a large team of scientists and a well-equipped array production platform and testing experiment platform, we can provide a broad and comprehensive combination of laboratories and manufacturing services. We have comprehensive capabilities and are committed to working with customers all over the world to meet your specific requirements. Please contact us for more details.
For research use only, not intended for any clinical use.
| Cat |
Product Name |
Inquiry |
Basket |
| + CDPPM-17 |
Autoimmune Epitope Microarray |
Inquiry
|
|
| Description: The probe content is nearly 4000 B cell epitopes related to autoimmune diseases in the immune epitope database, including 286 citrullinated peptides and corresponding arginine variants. |
| + CDPPM-18 |
Allergen Epitope Microarray |
Inquiry
|
|
| Description: The probe content is designed based on 4,022 linear allergen epitopes of 223 different allergens cited in the immune epitope database. |
| + CDPPM-19 |
Melanoma Antigen Microarray |
Inquiry
|
|
| Description: The probe content contains 21 overlapping peptides that are linked and translated into melanoma-related tumor antigens with a neutral GS linker. |
| + CDPPM-20 |
Lupus Microarray |
Inquiry
|
|
| Description: The probe content is 28 selected lupus autoantigens from the immune epitope database and an additional 789 linear lupus epitopes, including post-translational modifications such as citrulline and acetyllysine. |
| + CDPPM-21 |
Oncovirus Epitope Microarray |
Inquiry
|
|
| Description: The probe content is 3653 human cancer virus linear B cell epitopes from the immune epitope database, including 7 citrullinated peptides and corresponding arginine variants. |
| + CDPPM-22 |
Tumor Antigen Microarray |
Inquiry
|
|
| Description: The probe content is histone H1.2, histone H4, G2/mitotic-specific cyclin-B1, L-dopachrome tautomerase, p53, receptor tyrosine-protein kinase erbB-2 , mammaglobin A, TCRgamma alternate reading frame protein, stromelysin-3, and so on. |
| + CDPPM-23 |
BK Polyomavirus Antigen Microarray |
Inquiry
|
|
| Description: The probe content is the small T antigen, large T antigen, major capsid proteins VP1, VP2 and VP3 of BKPyV (BKPyV). |
| + CDPPM-24 |
Rheumatoid Arthritis (RA) Antigen Microarray |
Inquiry
|
|
| Description: The probe contains a synovial proteome-related antigen peptide-related collection, including 225 peptides and proteins representing candidate and control antigens. |
